Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase mitochondrial F1 complex assembly factor 2 (ATPAF2) is a protein required for the assembly of the F1 component of the mitochondrial ATP synthase, an essential enzyme complex that produces ATP in mitochondria. ATPAF2 specifically binds to the F1 alpha subunit, where it is thought to prevent this subunit from forming nonproductive homooligomers during assembly, thereby ensuring correct complex formation[1][5][6][7]. Mutations in ATPAF2 can lead to diseases such as mitochondrial complex V deficiency, and the gene is located within the Smith-Magenis syndrome critical region[1]. ATPAF2 is not a classical druggable target (such as a receptor, enzyme, or transporter) but is a chaperone-like assembly factor, making it functionally distinct from canonical pharmacological targets[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase mitochondrial F1 complex assembly factor 2 (ATPAF2).